相关实验视频

Updated: Jun 28, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

在CT扫描上COVID-19胸部表现和发展肺纤维化相关风险因素

Noha Bakhsh¹, Mai Banjar²

¹Department of Medicine, Division of Radiology, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, SAU.

|April 22, 2024

概括

肺纤维化发生在9.6%的2019年冠状病毒病 (COVID-19) 患者中. 高血压和冠状动脉疾病是COVID-19后发展肺纤维化的危险因素.

科学领域:

放射学放射学是一门学科.
肺部病理学肺部病理学
传染性疾病传染性疾病

背景情况:

冠状病毒疾病2019 (COVID-19) 可能导致长期呼吸道并发症.
肺纤维化是严重的COVID-19肺炎的潜在后果.

研究的目的:

描述COVID-19患者胸部计算机断层扫描 (CT) 成像发现.
为了确定COVID-19后的肺纤维化患病率.
识别与发展肺纤维化相关的风险因素.

主要方法:

成年COVID-19患者胸部CT扫描的回顾性分析 (2020年1月 - 2022年4月).
评估成像检测结果和肺部严重性评分 (PSS).
与有纤维化肺部变化和没有纤维化肺部变化患者之间的临床和放射学数据的比较.

主要成果:

肺纤维化在9.6%的患者中被发现.
高血压和冠状动脉疾病 (CAD) 与肺纤维化风险的增加有显著关联.
肺纤维化患者的肺炎严重程度得分更高,住院时间更长.

结论:

肺纤维化是COVID-19幸存者的一个显著并发症.
建议对患有严重肺炎,长时间住院,高血压或CAD的患者进行密切监测.
进一步进行大规模的长期研究是有必要的,以充分了解COVID-19相关的肺纤维化.

关键词:

这种疾病是共患的.计算机断层扫描 (ct)在COVID-19中,有很多人.肺部纤维化肺部纤维化风险因素的风险因素是什么

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

相关概念视频

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.